without
diagnost
medicin
blind
alain
merieux
diagnost
laboratori
servic
label
achil
heel
global
past
low
qualiti
diagnost
ineffect
laboratori
servic
result
mistrust
laboratori
result
turn
led
decreas
demand
laboratori
servic
low
prioriti
maputo
declar
call
govern
multilater
agenc
develop
partner
profession
associ
academ
institut
address
laboratori
challeng
limit
scaleup
servic
tb
malaria
hiv
diagnosi
care
togeth
us
center
diseas
control
prevent
call
end
neglect
laboratori
provid
major
mileston
pathway
place
diagnost
laboratori
servic
import
pillar
healthcar
recent
outbreak
influenza
middl
east
respiratori
syndrom
coronaviru
merscov
ebola
viru
diseas
illustr
import
diagnost
outbreak
rapid
technolog
innov
last
year
donor
invest
develop
improv
diagnost
infecti
diseas
public
health
import
time
reexamin
achil
heel
explor
promis
challeng
diagnost
digit
age
accur
diagnost
test
play
key
role
clinician
trust
patient
manag
diagnost
test
tradit
consid
tool
rule
rule
condit
infect
clinic
present
patient
nonspecif
diseas
hiv
sexual
transmit
infect
infect
asymptomat
caus
seriou
longterm
consequ
diagnost
use
screen
infect
treatment
given
prevent
develop
longterm
complic
interrupt
chain
transmiss
sexual
partner
fetu
case
pregnant
women
test
human
papillomaviru
help
determin
risk
diseas
progress
cervic
cancer
pathogen
develop
antibiot
resist
neisseria
gonorrhoea
diagnost
test
use
determin
antibiot
suscept
ensur
treatment
efficaci
hiv
patient
test
result
use
determin
patient
elig
antiretrovir
treatment
treatment
viral
load
assay
use
determin
treatment
complianc
drug
efficaci
test
cure
use
determin
treatment
stop
figur
beyond
patient
manag
diagnost
play
critic
role
variou
aspect
public
health
diseas
prevent
control
diagnost
critic
surveil
monitor
trend
diseas
antimicrobi
resist
assess
impact
intervent
diagnost
tool
suffici
sensit
specif
detect
level
infect
lead
transmiss
identifi
one
three
essenti
requir
diseas
elimin
set
erad
elimin
target
number
neglect
tropic
diseas
ntd
includ
guinea
worm
polio
yaw
trachoma
schistosomiasi
lymphat
filariasi
onchocerciasi
human
african
trypanosomiasi
chaga
diseas
viscer
leishmaniasi
vl
elimin
mother
child
transmiss
emtct
hiv
syphili
mass
drug
administr
mda
main
control
strategi
mani
diseas
result
need
highli
sensit
test
detect
remain
case
area
low
transmiss
intens
multipl
round
mda
highli
specif
test
need
certifi
elimin
maintain
postelimin
surveil
often
littl
commerci
interest
develop
diagnost
use
mainli
surveil
low
return
invest
ntd
schistosomiasi
chines
nation
control
programm
defin
stage
schistosomiasi
control
morbid
control
preval
defin
stool
examin
infect
control
preval
transmiss
control
preval
lower
transmiss
interrupt
case
detect
year
success
elimin
case
detect
year
transmiss
interrupt
diagnost
result
use
inform
nation
region
control
polici
redirect
resourc
transit
next
phase
control
treatment
target
emtct
whounaid
target
hiv
also
includ
diagnost
test
coverag
indic
effici
servic
deliveri
help
countri
set
cours
aid
free
gener
end
hiv
epidem
beadbas
technolog
versatil
potenti
offer
higher
sensit
compar
tradit
solid
phase
instead
use
enzymat
amplif
colorimetr
substrat
beadbas
assay
use
rang
label
includ
laser
fluoresc
detect
bind
secondari
antibodi
antigen
antibodi
target
bead
solut
offer
site
ligand
bind
compar
solid
phase
support
fluoresc
intens
yield
quantit
result
protein
array
offer
potenti
quantif
antigen
target
surrog
measur
bacteri
parasit
viral
load
inform
treatment
strategi
detect
multipl
target
pathogen
lead
increas
effici
singletarget
assay
detect
target
multipl
pathogen
use
singl
specimen
offer
substanti
cost
sampl
save
tradit
elisa
measur
detect
platform
often
equip
data
transmiss
capac
allow
near
realtim
surveil
diseas
trend
monitor
effect
special
intervent
microfluid
devic
offer
mani
advantag
high
throughput
short
analysi
time
small
volum
high
sensit
make
ideal
immunoassay
format
clinic
diagnos
current
microfluid
immunoassay
limit
multiplex
capabl
compar
flow
cytometr
assay
improv
immunoassay
develop
microfluid
platform
reproduc
step
tradit
elisa
miniaturis
format
microfluid
disc
fit
palm
hand
rapid
inexpens
manufactur
platform
allow
multiplex
valid
antibodi
detect
blood
sampl
antigen
detect
urin
stool
sampl
requir
multistep
specimen
process
andor
purif
concentr
put
antigenantibodi
reaction
within
microfluid
channel
recent
public
show
possibl
use
power
smart
phone
power
microfluid
immunoassay
reaction
plug
reaction
chamber
smart
phone
use
assay
run
recharg
necessari
result
interpret
display
phone
data
transmit
central
databas
requir
dual
test
detect
antibodi
hiv
syphili
design
platform
util
improv
access
prenat
screen
also
allow
surveil
data
dual
elimin
mtct
hiv
syphili
avail
real
grow
number
promis
diagnost
tool
base
nanotechnolog
applic
nanomateri
detect
host
pathogen
biomark
potenti
yield
ultrasensit
assay
quantum
dot
fluoresc
semiconductor
nanoparticl
typic
atom
diamet
technolog
appli
develop
ultrasensit
test
hiv
viral
also
possibl
use
technolog
combin
pathogen
detect
speciat
genet
analysi
detect
singl
nucleotid
polymorph
henc
use
high
throughput
screen
drug
mutat
target
quantum
wire
use
develop
fulli
autom
diagnost
test
malaria
infect
speciat
drug
resist
statu
less
nanosensor
ultim
configur
handheld
pdatyp
devic
thin
plate
size
small
busi
card
contain
tini
nanowir
sensor
oper
test
simpl
use
give
answer
less
minut
use
doctor
visit
home
patient
earli
detect
bioterror
commun
set
link
mobil
connect
gp
enabl
anonymis
diseas
data
sent
data
cloud
realtim
surveil
advocaci
appli
novel
technolog
ntd
antimicrobi
resist
monitor
urgent
prioriti
requir
precis
engin
nanomateri
surfac
interfac
nanomateri
specimen
reaction
occur
molecular
assay
offer
superior
diagnost
perform
compar
limit
detect
immunoassay
last
two
decad
nucleic
acid
amplif
test
naat
becom
gold
refer
standard
perform
diagnost
test
compar
recent
remain
larg
laboratori
base
expens
inaccess
number
poc
molecular
assay
without
amplif
horizon
may
transform
deliveri
health
first
sampleinanswerout
realtim
pcr
platform
use
wherev
sourc
electr
introduc
diagnosi
tb
detect
rifampicin
genexpert
realtim
pcr
platform
larg
menu
test
target
thu
allow
polyval
test
differ
pathogen
requir
minim
onsit
expertis
provid
result
less
hour
addit
advantag
random
access
remot
qualiti
control
howev
cartridg
expens
afford
sustain
unless
subsidis
high
burden
countri
maximis
impact
novel
technolog
critic
patient
pathway
modifi
take
advantag
speed
result
find
costeffici
mean
implement
compar
tradit
laboratori
isotherm
amplif
platform
helicas
depend
amplif
hda
cross
prime
amplif
cpa
recombinas
polymeras
amplif
rpa
loopmedi
amplif
lamp
assay
engin
poc
naat
requir
sophist
equip
perform
thermal
cycl
detail
technolog
describ
poc
naat
base
technolog
larg
appli
high
burden
diseas
hiv
tb
technolog
lamp
develop
evalu
diagnosi
vl
hat
case
vl
lamp
assay
leishmania
donovani
highli
sensit
specif
diagnosi
vl
use
blood
sampl
diagnosi
postkala
azar
dermal
leishmaniasi
pkdl
use
skin
biopsi
diagnosi
pkdl
import
elimin
agenda
sinc
patient
condit
import
sourc
infect
case
hat
lamp
assay
shown
sensit
ci
specif
ci
compar
pcr
refer
advocaci
invest
need
appli
technolog
control
elimin
simplest
poc
diagnost
test
wide
use
today
rapid
diagnost
test
rdt
later
flow
format
read
nake
eye
subject
prone
human
error
may
exacerb
poor
light
health
post
addit
rdt
lack
onboard
qualiti
control
often
use
remot
area
health
worker
receiv
minim
train
result
accuraci
rdt
perform
field
quit
variabl
may
advers
affect
patient
care
accuraci
data
gather
surveil
digit
imag
technolog
electron
reader
smart
phone
use
captur
interpret
rdt
result
transmit
data
given
larg
number
brand
rdt
hiv
malaria
syphili
would
ideal
diagnost
test
reader
could
accommod
varieti
test
technolog
eg
later
flow
immunofiltr
format
eg
strip
cassett
variou
size
shape
number
rdt
reader
alreadi
market
other
pipelin
given
widespread
adopt
smart
phone
resourcelimit
set
rdt
reader
use
technolog
potenti
combin
highresolut
test
imag
comput
capabl
requir
run
imag
analysi
softwar
transmit
data
reader
rang
price
depend
technic
complex
instrument
compat
type
rdt
data
collect
emtct
difficult
test
highli
decentralis
data
qualiti
difficult
verifi
track
global
progress
toward
elimin
mtct
hiv
syphili
mani
challeng
need
address
current
data
antenat
screen
need
manual
access
individu
test
site
electron
reader
rdt
abl
captur
automat
transmit
data
may
therefor
serv
critic
purpos
strengthen
data
collect
surveil
context
monitor
evalu
dual
realtim
data
monitor
via
electron
reader
could
help
improv
coordin
suppli
chain
manag
multipl
partner
oper
data
stock
devic
usag
condit
upload
via
wifi
cellular
network
transmit
central
databas
link
data
suppli
chain
manag
softwar
stockout
potenti
avoid
health
system
effici
improv
recent
year
rdt
introduc
increas
hiv
syphili
screen
antenat
clinic
enabl
day
test
treatment
infect
mother
prevent
advers
outcom
pregnanc
fetal
loss
emtct
target
achiev
pregnant
women
access
antenat
care
pregnant
women
antenat
care
test
hiv
syphili
test
posit
receiv
treatment
achiev
target
countri
need
system
track
progress
capac
ongo
surveil
elimin
target
achiev
studi
shown
introduct
rapid
rdt
syphili
prenat
syphili
screen
strengthen
health
system
improv
access
diagnost
health
worker
job
satisfact
reduc
stillbirth
neonat
mortal
peru
introduct
rdt
prenat
screen
result
infect
pregnant
women
screen
treat
singl
visit
instead
visit
decentralis
test
outsid
laboratori
put
tremend
stress
healthcar
system
present
challeng
train
qualiti
assur
test
decentralis
programm
manag
often
unabl
monitor
test
coverag
qualiti
make
difficult
identifi
problem
substandard
test
stockout
time
poc
molecular
devic
requir
instrument
calibr
ongo
mainten
frequenc
failur
power
usag
environment
sustain
also
consid
creation
central
databas
collect
surveil
data
villag
antenat
clinic
way
nation
global
databas
need
involv
obtain
consensu
host
data
data
collect
access
data
find
afford
softwar
middlewar
solut
provid
open
access
allow
rapid
coordin
transmiss
data
govern
technolog
need
ensur
data
collect
transmit
store
way
conform
ethic
legal
standard
maintain
patient
privaci
confidenti
govern
issu
may
resolv
ensur
separ
level
access
oper
data
versu
patient
data
addit
data
storag
inlin
countri
specif
regul
discuss
need
take
place
around
data
ownership
excel
exampl
nation
databas
inform
critic
programmat
decis
real
time
kenyan
nation
earli
infant
diagnosi
eid
portal
wwwnascoporgeid
extend
cover
hiv
viral
load
diagnost
databas
result
success
partnership
involv
govern
kenya
ministri
health
usaidpresid
emerg
plan
aid
relief
pepfar
us
cdc
clinton
health
access
initi
chai
hewlett
packard
safaricom
strathmor
univers
hewlett
packard
built
basic
data
centr
nation
aidsstd
control
programm
nascop
test
laboratori
earli
infant
diagnosi
safaricom
largest
provid
mobil
servic
kenya
set
short
code
servic
sm
strathmor
univers
student
built
applic
pepfar
cdc
chai
roll
eid
programm
countrywid
result
nation
eid
portal
run
govern
data
test
program
data
enter
comput
laboratori
equip
laboratori
inform
system
webbas
applic
health
facil
provid
eid
servic
access
data
test
result
sm
mobil
web
web
email
near
real
time
data
analyt
includ
sampl
transport
track
volum
test
facil
test
result
includ
number
reject
sampl
indetermin
result
result
deliv
via
electron
paper
mean
sm
printer
email
courier
web
real
time
eidprevent
mtct
programm
analyt
avail
onlin
facil
region
nation
level
new
gener
diagnost
equip
digit
technolog
transform
field
clinic
decisionmak
diseas
control
prevent
rapid
poc
test
infecti
diseas
improv
access
diagnosi
patient
manag
qualiti
test
vari
qualiti
test
often
assur
mechan
captur
test
result
surveil
test
decentralis
electron
reader
potenti
provid
fast
accur
standardis
rdt
interpret
realtim
data
report
huge
rang
posit
function
includ
improv
qualiti
assur
suppli
chain
manag
provid
accur
time
data
surveil
although
countri
need
consid
data
govern
confidenti
issu
data
connect
allow
control
programm
monitor
qualiti
test
test
optimis
suppli
chain
manag
thu
increas
effici
healthcar
system
improv
patient
outcom
